| Literature DB >> 27707892 |
Bassirou Diarra1, David Safronetz2, Yeya Dit Sadio Sarro1, Amadou Kone1, Moumine Sanogo1, Sady Tounkara1, Antieme C G Togo1, Fatoumata Daou1, Almoustapha I Maiga1, Sounkalo Dao1, Kyle Rosenke2, Darryl Falzarano2, Seydou Doumbia1, Kathryn C Zoon3, Michael Polis4, Sophia Siddiqui4, Samba Sow5, Tom G Schwan6, Heinz Feldmann2, Souleyman Diallo1, Ousmane A Koita1.
Abstract
Aware of the rapid spread of Ebola virus (EBOV) during the current West African epidemic, Mali took several proactive steps to rapidly identify cases within its borders. Under the Mali International Center for Excellence in Research program, a collaboration between the National Institute of Allergy and Infectious Diseases and the Malian Ministry of Higher Education and Scientific Research established a national EBOV diagnostic site at the University of Sciences, Techniques and Technologies of Bamako in the SEREFO Laboratory. Two separate introductions of EBOV occurred in Mali from neighboring Guinea, but both chains of transmission were quickly halted, and Mali was declared "Ebola free" on 18 January 2015 and has remained so since. The SEREFO Laboratory was instrumental in the success of Mali's Ebola response by providing timely and accurate diagnostics. As of today, the SEREFO Laboratory has tested 103 samples from 88 suspected cases, 10 of which were EBOV positive, since the Ebola diagnostics unit started in April 2014. The establishment of Ebola diagnostics in the SEREFO Laboratory, safety precautions, and diagnostics are described.Entities:
Keywords: Ebola virus; Mali; West Africa; diagnostics; epidemic
Mesh：
Year: 2016 PMID： 27707892 PMCID： PMC5050465 DOI： 10.1093/infdis/jiw200
Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226